Declaration of competing interest SL has received honoraria for service as a consultant or adviser and/or for lectures from Angelini, Apsen, Boehringer Ingelheim, Eisai, Ekademia, Gedeon Richter, Janssen, Johnson & Johnson, Karuna, Kynexis, LB Pharma, LTS Lohmann, Lundbeck, MSD, Medichem, Medscape, Mitsubishi, Neurotorium, NovaNordisk, Otsuka, Recordati, Sandoz, Sanofi-Aventis, Sunovion, Rovi and TEVA. EV has received grants and served as a consultant, advisor or CME speaker for the following entities: AB-Biotics, AbbVie, Adamed, Angelini, BeckleyPsych, Biogen, Biohaven, Boehringer-Ingelheim, Celon Pharma, Compass, Dainippon Sumitomo Pharma, Ethypharm, Ferrer, Gedeon Richter, GH Research, Glaxo-Smith Kline, HMNC, Idorsia, Janssen, Lundbeck, Luye Pharma, Medincell, Merck, Newron, Novartis, Orion Corporation, Organon, Otsuka, Roche, Rovi, Sage, Sanofi-Aventis, Sunovion, Takeda, Teva, and Viatris, outside of the submitted work. SS has received grants from Lundbeck, Sanofi-Aventis, and Servier outside of the submitted work. The other authors report no financial relationships with commercial interests.
PubMed
